Earnings Feed
Start Free
CLINICAL DATA INC·4

Apr 14, 3:30 PM ET

Reed Carol 4

4 · CLINICAL DATA INC · Filed Apr 14, 2011

Insider Transaction Report

Form 4
Period: 2011-04-12
CLINICAL DATA INCCLDA
Reed Carol
EVP and Chief Medical Officer
Transactions
  • Disposition from Tender

    Common Stock

    2010-04-12$30.00/sh−2,437$73,110→ 0 total
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13−2,048→ 0 total
    Exercise: $38.36Exp: 2014-04-25→ Common Stock (2,048 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13$7.43/sh−7,092$52,694→ 0 total
    Exercise: $22.57Exp: 2015-01-05→ Common Stock (7,092 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13$18.07/sh−10,656$192,554→ 0 total
    Exercise: $11.93Exp: 2015-12-23→ Common Stock (10,656 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13$15.01/sh−45,000$675,450→ 0 total
    Exercise: $14.99Exp: 2017-06-14→ Common Stock (45,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-12$13.05/sh−75,000$978,750→ 0 total
    Exercise: $16.95Exp: 2018-04-17→ Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-12$21.22/sh−75,000$1,591,500→ 0 total
    Exercise: $8.78Exp: 2018-12-22→ Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$13.46/sh−85,000$1,144,100→ 0 total
    Exercise: $16.54Exp: 2020-12-22→ Common Stock (85,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13−975→ 0 total
    Exercise: $133.54Exp: 2011-06-09→ Common Stock (975 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13−146→ 0 total
    Exercise: $46.15Exp: 2011-10-14→ Common Stock (146 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13$18.07/sh−18,000$325,260→ 0 total
    Exercise: $11.93Exp: 2015-10-15→ Common Stock (18,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13$17.63/sh−45,000$793,350→ 0 total
    Exercise: $12.37Exp: 2016-05-16→ Common Stock (45,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13$11.61/sh−85,000$986,850→ 0 total
    Exercise: $18.39Exp: 2019-12-21→ Common Stock (85,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13−975→ 0 total
    Exercise: $46.97Exp: 2011-12-31→ Common Stock (975 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13$3.75/sh−4,778$17,918→ 0 total
    Exercise: $26.25Exp: 2013-12-06→ Common Stock (4,778 underlying)
  • Disposition to Issuer

    Stock Option (right to buy

    2011-04-13$7.43/sh−1,194$8,871→ 0 total
    Exercise: $22.57Exp: 2015-01-05→ Common Stock (1,194 underlying)
Footnotes (2)
  • [F1]Pursuant to the Agreement and Plan of Merger dated February 22, 2011, as amended on April 4, 2011, by which Magnolia Acquisition Corp. merged with and into Clinical Data, Inc., this option was cancelled without consideration paid in connection with the completion of the merger.
  • [F2]This option, whether fully vested or not, was terminated upon the completion of the merger of Magnolia Acquisition Corp. with and into Clinical Data, Inc. pursuant to the Agreement and Plan of Merger dated February 22, 2011, as amended on April 4, 2011. Pursuant to the Agreement and Plan of Merger, the option was converted into the right to receive $30.00 per share (minus the exercise price of the option) in cash plus contingent consideration of up to $6.00 per share that may be paid upon achievement of certain commercial milestones, subject to any applicable tax withholdings.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION